BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 2593915)

  • 21. Phlebitis induced by parenteral treatment with flucloxacillin and cloxacillin: a double-blind study.
    Svedhem A; Alestig K; Jertborn M
    Antimicrob Agents Chemother; 1980 Aug; 18(2):349-52. PubMed ID: 7447412
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cholestasis secondary to Hodgkin's disease: report of 2 cases of vanishing bile duct syndrome.
    de Medeiros BC; Lacerda MA; Telles JE; da Silva JA; de Medeiros CR
    Haematologica; 1998 Nov; 83(11):1038-40. PubMed ID: 9864926
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative bioavailability and half-lives of cloxacillin and flucloxacillin.
    Paton DM
    Int J Clin Pharmacol Res; 1986; 6(5):347-9. PubMed ID: 3781696
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Flucloxacillin-associated hepatic injury.
    Koek GH; Stricker BH; Blok AP; Schalm SW; Desmet VJ
    Liver; 1994 Oct; 14(5):225-9. PubMed ID: 7997079
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Terbinafine-induced prolonged cholestasis with reduction of interlobular bile ducts.
    Mallat A; Zafrani ES; Metreau JM; Dhumeaux D
    Dig Dis Sci; 1997 Jul; 42(7):1486-8. PubMed ID: 9246051
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inadvertent intra-arterial injection of flucloxacillin.
    Zideman DA; Morgan M
    Anaesthesia; 1981 Mar; 36(3):296-8. PubMed ID: 7224122
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Flucloxacillin sodium.
    Aust Nurses J; 1980 Sep; 10(3):30-1. PubMed ID: 6904199
    [No Abstract]   [Full Text] [Related]  

  • 28. Cloxacillin-induced acute vanishing bile duct syndrome: A case study and literature review.
    Faragalla K; Lau H; Wang HL; Liu J
    Br J Clin Pharmacol; 2022 Oct; 88(10):4633-4638. PubMed ID: 35730139
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Light and electron microscopic study of the liver in paraquat poisoning.
    Takegoshi K; Nakanuma Y; Ohta M; Thoyama T; Okuda K; Kono N
    Liver; 1988 Dec; 8(6):330-6. PubMed ID: 3216772
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Flucloxacillin-induced liver injury.
    Andrews E; Daly AK
    Toxicology; 2008 Dec; 254(3):158-63. PubMed ID: 18793693
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cholestatic jaundice due to derivatives of oxacillin.
    Deboever G
    Am J Gastroenterol; 1987 May; 82(5):483. PubMed ID: 3578231
    [No Abstract]   [Full Text] [Related]  

  • 32. Cephradine and flucloxacillin in the prophylaxis of infection in patients with open fractures.
    Alpar EK
    J Clin Pharm Ther; 1988 Apr; 13(2):117-20. PubMed ID: 3392125
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cholestatic liver disease with ductopenia (vanishing bile duct syndrome) after administration of clindamycin and trimethoprim-sulfamethoxazole.
    Altraif I; Lilly L; Wanless IR; Heathcote J
    Am J Gastroenterol; 1994 Aug; 89(8):1230-4. PubMed ID: 8053440
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clostridium difficile isolated from the stool of a patient with pseudomembranous colits following ampicillin plus flucloxacillin (Magnapen) therapy.
    Morgan RJ; Gemmell CG; Lee FD; Lang W; Russell RI
    Postgrad Med J; 1980 Jan; 56(651):65-6. PubMed ID: 7383956
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Severe intrahepatic cholestasis caused by amiodarone toxicity after withdrawal of the drug: a case report and review of the literature.
    Chang CC; Petrelli M; Tomashefski JF; McCullough AJ
    Arch Pathol Lab Med; 1999 Mar; 123(3):251-6. PubMed ID: 10086516
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tetracycline-induced bile duct paucity and prolonged cholestasis.
    Hunt CM; Washington K
    Gastroenterology; 1994 Dec; 107(6):1844-7. PubMed ID: 7958700
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Peripheral bile duct paucity and cholestasis in the liver of a patient with Alagille syndrome: further evidence supporting a lack of postnatal bile duct branching and elongation.
    Libbrecht L; Spinner NB; Moore EC; Cassiman D; Van Damme-Lombaerts R; Roskams T
    Am J Surg Pathol; 2005 Jun; 29(6):820-6. PubMed ID: 15897750
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Flucloxacillin compared with cefazolin in short-term prophylaxis for clean orthopedic surgery.
    Van Meirhaeghe J; Verdonk R; Verschraegen G; Myny P; Paeme G; Claessens H
    Arch Orthop Trauma Surg; 1989; 108(5):308-13. PubMed ID: 2783023
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Flucloxacillin (floxapen) in the treatment of skin and upper respiratory tract infections.
    Crofts HG
    N Z Med J; 1978 May; 87(611):308-11. PubMed ID: 276701
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Endothelial damage caused by the semisynthetic penicillins cloxacillin dicloxacillin and flucloxacillin].
    Sinapius D; BrĂ¼ndel KH
    Vasa; 1975; 4(1):54-8. PubMed ID: 1189592
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.